I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 47 500 VND -2.06% Market Closed
Market Cap: 7.3T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Imexpharm Corp
Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Imexpharm Corp
Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
I
Imexpharm Corp
VN:IMP
Cash
â‚«143.4B
CAGR 3-Years
50%
CAGR 5-Years
15%
CAGR 10-Years
11%
H
HaTay Pharmaceutical JSC
VN:DHT
Cash
â‚«89.3B
CAGR 3-Years
3%
CAGR 5-Years
13%
CAGR 10-Years
8%
C
Cuu Long Pharmaceutical JSC
VN:DCL
Cash
â‚«23.5B
CAGR 3-Years
22%
CAGR 5-Years
1%
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Cash
â‚«16.2B
CAGR 3-Years
-37%
CAGR 5-Years
-26%
CAGR 10-Years
-8%
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Cash
â‚«76.4B
CAGR 3-Years
7%
CAGR 5-Years
9%
CAGR 10-Years
-5%
T
Traphaco JSC
VN:TRA
Cash
â‚«169.5B
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
7%
No Stocks Found

Imexpharm Corp
Glance View

Market Cap
7.3T VND
Industry
Pharmaceuticals

Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

IMP Intrinsic Value
27 228.06 VND
Overvaluation 43%
Intrinsic Value
Price
I

See Also

What is Imexpharm Corp's Cash?
Cash
143.4B VND

Based on the financial report for Sep 30, 2024, Imexpharm Corp's Cash amounts to 143.4B VND.

What is Imexpharm Corp's Cash growth rate?
Cash CAGR 10Y
11%

Over the last year, the Cash growth was 111%. The average annual Cash growth rates for Imexpharm Corp have been 50% over the past three years , 15% over the past five years , and 11% over the past ten years .

Back to Top